| Financial Year |
March 31 2023 |
| Monetary Funds |
1,662,470,302.28 |
| Held-for-trading Financial Assets |
1,498,209.03 |
| Notes Receivable |
8,179,746.80 |
| Accounts Receivable |
290,986,426.57 |
| Advances to Suppliers |
1,365,872.77 |
| Other Receivables |
367,541.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
162,957,996.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,435,732.49 |
| Total Current Assets |
2,143,735,416.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,497,457.04 |
| Fixed Assetes |
509,137,117.12 |
| Under-construction Projects |
47,225,284.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
59,052,760.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,826,590.93 |
| Other Non-Current Assets |
2,752,677.53 |
| Sub-Total of Non-Current Assets |
727,309,881.24 |
| Total Assets |
2,871,045,298.04 |
| Short-Term Loans |
2,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
118,570,652.16 |
| Accounts Payable |
201,993,931.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,159,440.72 |
| Taxes Payable |
5,118,217.67 |
| Interest Payable |
1,942,784.31 |
| Dividend Payable |
-- |
| Other payables |
39,448,848.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,474,438.38 |
| Other Current Liabilities |
270,743.02 |
| Sub-Total of Current Liabilities |
400,931,641.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,705,508.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,808,564.55 |
| Total Liabilities |
482,740,205.83 |
| Paid-In Capital(Or Share Stock) |
70,929,872.00 |
| Capital Surplus |
1,219,961,857.92 |
| Surplus Reserve |
157,602,397.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
913,087,281.74 |
| Minority Stockholder's Interest |
26,723,683.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,361,581,408.94 |
| Owner's Equity（Stockholder's Equity） |
2,388,305,092.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,871,045,298.04 |
